Akureyri disease
Akureyri disease (pronunciation: ah-koo-rey-ree disease) is a medical condition also known as Myalgic Encephalomyelitis (ME) or Chronic Fatigue Syndrome (CFS). The term "Akureyri disease" originated from the town of Akureyri in Iceland where an outbreak of the disease was first reported in the 1940s.
Etymology
The term "Akureyri disease" is derived from the name of the town in Iceland where the disease was first identified. The term "Myalgic Encephalomyelitis" is of Greek origin: "myalgia" meaning muscle pain, "encephalo" referring to the brain, and "itis" indicating inflammation.
Symptoms
The symptoms of Akureyri disease include persistent fatigue, post-exertional malaise, unrefreshing sleep, cognitive impairment, and orthostatic intolerance. These symptoms can vary in severity and duration, and may be accompanied by additional symptoms such as muscle and joint pain, headaches, and flu-like symptoms.
Diagnosis
Diagnosis of Akureyri disease is primarily based on the patient's medical history and symptom presentation, as there is currently no definitive diagnostic test for the condition. The Fukuda criteria and the Canadian Consensus Criteria are commonly used diagnostic criteria for Akureyri disease.
Treatment
Treatment for Akureyri disease primarily focuses on managing symptoms and improving quality of life. This may include medication for pain and sleep disturbances, physical therapy, and cognitive behavioral therapy.
See also
References
External links
- Medical encyclopedia article on Akureyri disease
- Wikipedia's article - Akureyri disease
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski